Analytical and bioanalytical method validation of olaparib and tazemetostat by AQbD approach: supporting pre-clinical applications through in-silico modelling against breast cancer therapy
Analytical and bioanalytical method validation of olaparib and tazemetostat by AQbD approach: supporting pre-clinical applications through in-silico modelling against breast cancer therapy. // Microchemical Journal. – URL: https://www.sciencedirect.com/science/article/pii/S0026265X26034156?dgcid=rss_sd_all
Analytical and bioanalytical method validation of olaparib and tazemetostat by AQbD approach: supporting pre-clinical applications through in-silico modelling against breast cancer therapy. Microchemical Journal. https://www.sciencedirect.com/science/article/pii/S0026265X26034156?dgcid=rss_sd_all
“Analytical and bioanalytical method validation of olaparib and tazemetostat by AQbD approach: supporting pre-clinical applications through in-silico modelling against breast cancer therapy.” Microchemical Journal.
@article{article75302,
title = {Analytical and bioanalytical method validation of olaparib and tazemetostat by AQbD approach: supporting pre-clinical applications through in-silico modelling against breast cancer therapy},
journal = {Microchemical Journal},
url = {https://www.sciencedirect.com/science/article/pii/S0026265X26034156?dgcid=rss_sd_all}
}